Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes

Chemistry and Biology

Volumn 6, Issue 4, 1999, Pages 197-204

  Loidl, Günther ^a   Groll, Michael ^a   Musiol, Hans Jürgen ^a   Ditzel, Lars ^a   Huber, Robert ^a   Moroder, Luis ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Eukaryotic proteasome; Selective inhibition; Trypsin like activity; X ray analysis

Indexed keywords

EID: 0033117370     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(99)80036-2     Document Type: Article

References (42)

1. Goldberg, A.L., Stein, R. & Adams, J. (1995). New insights into proteasome function - from archaebacteria to drug development. Chem. Biol. 2, 503-508.
2. Hochstrasser, M. (1995). Ubiquitin, proteasomes, and the regulation of the intracellular protein degradation. Curr. Opin. Cell Biol. 7, 215-223.
3. Coux, O., Tanaka, K. & Goldberg, A.L. (1996). Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801-847.
4. Stock, D., Nederlof, P.M., Seemüller, E., Baumeister, W., Huber, R. & Löwe, J. (1996). Proteasome: From structure to function. Curr. Opin. Biotech. 7, 376-385.
5. Chen, P. & Hochstrasser, M. (1995). Biogenesis, structure and function of the yeast 20S proteasome. EMBO J. 14, 2620-2630.
6. Groettrup, M., Soza, A., Kuckelkorn, U. & Kloetzel. P.M. (1996). Peptide antigen production by the proteasome: Complexity provides efficiency. Immunol. Today 17, 429-435.
7. Hilt, W. & Wolf, D.H. (1996). Proteasomes: Destruction as a programme. Trends Biochem. Sci. 21, 96-102.
8. Baumeister, W., Walz, J., Zühl, F. & Seemüller, E. (1998). The proteasome: Paradigm of a self-compartmentalizing protease. Cell 92, 367-380.
9. Groll, M., et al., & Huber, R. (1997). Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature 386, 463-471.
10. Heinemeyer, W., Fischer, M., Krimmer, T., Stachon, U. & Wolf, D.H. (1997). The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing. J. Biol. Chem. 272, 25200-25209.
11. Nussbaum, A.K., et al, & Schild, H. (1998). Cleavage motifs of the yeast 20S proteasome β subunits deduced from digests of enolase I. Proc. Natl Acad. Sci. USA 95, 12504-12509.
12. Arendt, C.S. & Hochstrasser M. (1997). Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation. Proc. Natl Acad. Sci. USA 94, 7156-7161.
13. Lee, D.H. & Goldberg, A.L. (1998). Proteasome inhibitors: Valuable new tools for cell biologists. Trends Cell Biol. 8, 397-403.
14. Spaltenstein, A., et al., & Crouch, R. (1996). Design and synthesis of novel protease inhibitors: Tripeptide α', β'-epoxyketones as nanomolar inactivators of the proteasome. Tetrahedron Lett. 37, 1343-1346.
15. Reidlinger, J., Pike, A.M., Savory, P.J., Murray, R.Z. & Rivett, A.J. (1997). Catalytic properties of 26S and 20S proteasomes and radiolabeling of MB1, LMP7 and C7 subunits associated with trypsin-like and chymotrypsin-like activities. J. Biol. Chem. 272, 24899-24905.
16. Pereira, M.E., Nguyen, T., Wagner, B.J., Margolis, J.W., Yu, B. & Wilk, S. (1992). 3,4-Dichloroisocumarin-induced activation of the degradation of beta casein by the bovine pituitary multicatalytic proteinase complex. J. Biol. Chem. 267, 7949-7955.
17. Cardozo, C., Vinitsky, A., Hidalgo, M.C., Michaud, C. & Orlowski, M. (1992). A 3,4-Dichloroisocumarin-resistant component of the multicatalytic proteinase complex. Biochemistry 31, 7373-7380.
18. Akopian, T.N., Kisselev, A.F. & Goldberg, A.L. (1997). Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum. J. Biol. Chem. 272, 1791-1798.
19. 14C]-3,4-Dichloroisocumarin with subunits of pituitary and spleen multicatalytic proteinase complexes (proteasomes). Biochemistry 36, 13946-13953.
20. Fenteany, G., Standaert, R.F., Lane, W.S., Choi, S., Corey, E.J. & Schreiber, S.L. (1995). Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268, 726-731.
21. Dick L.R., et al., & Stein R.L. (1997). Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J. Biol. Chem. 272, 182-188.
22. Corey, E.J., Reichard, G.A. & Kania, R. (1993). Studies on the total synthesis of lactacystin: An improved aldol coupling reaction and a beta-lactone intermediate in thiol ester formation. Tetrahedron Lett. 34, 6977-6980.
23. McCormack, T.A., et al., & Dick, L.R. (1998). Kinetic studies of the branched chain amino acid preferring activity of the 20S proteasome: Development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin β-lactone. Biochemistry 37, 7792-7800.
24. Bogyo, M., McMaster, J.S., Gaczynska, M., Tortorella, D., Goldberg, A.L. & Ploegh, H. (1997). Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors. Proc. Natl Acad. Sci. USA 90, 6629-6634.
25. Bogyo, M., Shin, S., McMaster, J.S. & Ploegh, H. (1998). Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. Chem. Biol. 5, 307-320.
26. Adams, J. & Stein, R. (1996). Novel inhibitors of the proteasome and their therapeutic use in inflammation. Annu. Rep. Med. Chem. 31, 279-288.
27. Ostrowska, H., Omura, S., Wojcik, C. & Worowski, K. (1997). Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme. Biochem. Biophys. Res. Comm. 234, 729-732.
28. Rivett, A.J. (1989). The multicatalytic proteinase. J. Biol. Chem. 264, 12215-12219.
29. Dick, L.R., Moomaw, C.R., Pramanik, G.N., DeMartino, G.N. & Slaughter, C.A. (1992). Identification and localization of a cysteinyl residue critical for the trypsin-like catalytic activity of the proteasome. Biochemistry 31, 7347-7355.
30. Spike, C.G. & Parry, R.W. (1953). Thermodynamics of chelation. I. The statistical factor in chelate ring formation. J. Am. Chem. Soc. 75, 2726-2729.
31. Crothers, D.M. & Metzger, H. (1972). The influence of polyvalency on the binding properties of antibodies. Immunochemistry 9, 341-357.
32. Schaschke, N., Musiol, H.-J., Assfalg-Machleidt, I., Machleidt, W., Rudolph-Böhner, S. & Moroder, L. (1996). Cyclodextrins as templates for the presentation of protease inhibitors. FEBS Lett. 391, 297-301.
33. Romano, R., Bayerl, T.M. & Moroder, L. (1993). Lipophilic derivatization and its effect on the interaction of cholecystokinin (CCK) nonapeptide with phospholipids. Biochim. Biophys. Acta 1151, 111-119.
34. Smyth, D.G. (1964). Reactions of N-ethylmaleimide with peptides and amino acids. Biochem. J. 91, 589-595.
35. α-maleoylpeptide derivatives. Biol. Chem. Hoppe-Seyler 366, 53-61.
36. Löwe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W. & Huber, R. (1995). Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution. Science 268, 533-539.
37. KB Activity. Patent WO 95/25533.
38. Stein, R.L., Melandri, F. & Dick, L. (1996). Kinetic characterization of the chymotryptic activity of the 20S proteasome. Biochemistry 35, 3899-3908.
39. Brunger, A. (1992). X-PLOR Version 3.1. A System for X-Ray Crystallography and NMR.
40. Turk, D. (1992). Improvement of a Program for Molecular Graphics and Manipulation of Electron-Densities and its Application for Protein-Structure Determination. Thesis, Technische Universität München.
41. Jones, T.A. (1978). A graphic model building and refinement system for macromolecules. J. Appl. Crystallogr. 11, 268-272.
42. Engh, R.A. & Huber, R. (1991 ). Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallogr. A 47, 392-400.